José A. Gómez-Vidal

791 total citations
30 papers, 623 citations indexed

About

José A. Gómez-Vidal is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, José A. Gómez-Vidal has authored 30 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in José A. Gómez-Vidal's work include Histone Deacetylase Inhibitors Research (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and biological activity (4 papers). José A. Gómez-Vidal is often cited by papers focused on Histone Deacetylase Inhibitors Research (7 papers), Chemical Synthesis and Analysis (6 papers) and Synthesis and biological activity (4 papers). José A. Gómez-Vidal collaborates with scholars based in Spain, Mexico and United States. José A. Gómez-Vidal's co-authors include Richard B. Silverman, Mónica Díaz‐Gavilán, Miguel Á. Gallo, Antonio Espinosa, Joaquín M. Campos Rosa, José Correa‐Basurto, Yudibeth Sixto‐López, Juan Antonio Marchal, Antonia Aránega and Fernando Rodríguez‐Serrano and has published in prestigious journals such as Biochemistry, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

José A. Gómez-Vidal

30 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
José A. Gómez-Vidal Spain 16 301 277 114 66 40 30 623
Youhong Hu China 16 262 0.9× 203 0.7× 125 1.1× 71 1.1× 86 2.1× 39 772
Annalisa Masi Italy 21 614 2.0× 122 0.4× 55 0.5× 84 1.3× 18 0.5× 48 923
Danish Idrees India 14 426 1.4× 207 0.7× 35 0.3× 36 0.5× 18 0.5× 21 754
Yaroslav V. Tkachev Russia 18 265 0.9× 318 1.1× 112 1.0× 45 0.7× 44 1.1× 44 794
Zeki Topçu Türkiye 16 334 1.1× 218 0.8× 73 0.6× 53 0.8× 13 0.3× 33 596
Stefano Amatori Italy 18 459 1.5× 92 0.3× 26 0.2× 179 2.7× 15 0.4× 34 816
Daniele M. Leonard United States 12 323 1.1× 178 0.6× 61 0.5× 107 1.6× 14 0.3× 17 481
Yuan Fu China 14 510 1.7× 260 0.9× 91 0.8× 87 1.3× 7 0.2× 29 879
Y. V. V. Srikanth India 15 344 1.1× 590 2.1× 25 0.2× 72 1.1× 26 0.7× 24 880
Dmitry A. Skvortsov Russia 20 398 1.3× 643 2.3× 115 1.0× 169 2.6× 21 0.5× 105 1.2k

Countries citing papers authored by José A. Gómez-Vidal

Since Specialization
Citations

This map shows the geographic impact of José A. Gómez-Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Gómez-Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Gómez-Vidal more than expected).

Fields of papers citing papers by José A. Gómez-Vidal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Gómez-Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Gómez-Vidal. The network helps show where José A. Gómez-Vidal may publish in the future.

Co-authorship network of co-authors of José A. Gómez-Vidal

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Gómez-Vidal. A scholar is included among the top collaborators of José A. Gómez-Vidal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Gómez-Vidal. José A. Gómez-Vidal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sixto‐López, Yudibeth, Cynthia Ordaz‐Pichardo, José A. Gómez-Vidal, Martha Cecilia Rosales‐Hernández, & José Correa‐Basurto. (2023). Cytotoxic evaluation of YSL-109 in a triple negative breast cancer cell line and toxicological evaluations. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(6). 1211–1222. 2 indexed citations
2.
Corpas‐López, Victoriano, Victoriano Díaz‐Sáez, Francisco Morillas‐Márquez, et al.. (2022). Effectiveness of an O-Alkyl Hydroxamate in Dogs with Naturally Acquired Canine Leishmaniosis: An Exploratory Clinical Trial. Animals. 12(19). 2700–2700. 2 indexed citations
3.
Moya-Garzón, María Dolores, Cristina Martín-Higueras, Miguel X. Fernandes, et al.. (2022). New salicylic acid derivatives, double inhibitors of glycolate oxidase and lactate dehydrogenase, as effective agents decreasing oxalate production. European Journal of Medicinal Chemistry. 237. 114396–114396. 13 indexed citations
4.
Sixto‐López, Yudibeth, Manuel Jonathan Fragoso-Vázquez, Martha Cecilia Rosales‐Hernández, et al.. (2021). Targeting Several Biologically Reported Targets of Glioblastoma Multiforme by Assaying 2D and 3D Cultured Cells. Cellular and Molecular Neurobiology. 42(6). 1909–1920. 1 indexed citations
5.
Sixto‐López, Yudibeth, José A. Gómez-Vidal, Nuria de Pedro, et al.. (2021). In silico design of HDAC6 inhibitors with neuroprotective effects. Journal of Biomolecular Structure and Dynamics. 40(24). 14204–14222. 3 indexed citations
6.
Moya-Garzón, María Dolores, José A. Gómez-Vidal, Alfonso Alejo‐Armijo, et al.. (2021). Small Molecule-Based Enzyme Inhibitors in the Treatment of Primary Hyperoxalurias. Journal of Personalized Medicine. 11(2). 74–74. 1 indexed citations
7.
Méndez-Luna, David, Martiniano Bello, Itzia I. Padilla‐Martínez, et al.. (2021). Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells. Pharmaceuticals. 14(1). 49–49. 9 indexed citations
8.
Sixto‐López, Yudibeth, José A. Gómez-Vidal, Nuria de Pedro, et al.. (2020). Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines. Scientific Reports. 10(1). 10462–10462. 42 indexed citations
9.
Corpas‐López, Victoriano, Yudibeth Sixto‐López, Francisco Morillas‐Márquez, et al.. (2020). O-Alkyl Hydroxamates Display Potent and Selective Antileishmanial Activity. Journal of Medicinal Chemistry. 63(11). 5734–5751. 11 indexed citations
10.
Moya-Garzón, María Dolores, Cristina Martín-Higueras, Pablo Peñalver, et al.. (2018). Salicylic Acid Derivatives Inhibit Oxalate Production in Mouse Hepatocytes with Primary Hyperoxaluria Type 1. Journal of Medicinal Chemistry. 61(16). 7144–7167. 20 indexed citations
11.
Corpas‐López, Victoriano, Mónica Díaz‐Gavilán, Gemma Merino‐Espinosa, et al.. (2018). A nanodelivered Vorinostat derivative is a promising oral compound for the treatment of visceral leishmaniasis. Pharmacological Research. 139. 375–383. 18 indexed citations
12.
Gómez-Vidal, José A., et al.. (2014). Synthesis of l-Octaarginine through Microencapsulated Palladium-Catalyzed Allyl Ester Deprotection. Synlett. 25(16). 2319–2322. 5 indexed citations
13.
Sixto‐López, Yudibeth, José A. Gómez-Vidal, & José Correa‐Basurto. (2014). Exploring the Potential binding Sites of Some Known HDAC Inhibitors on Some HDAC8 Conformers by Docking Studies. Applied Biochemistry and Biotechnology. 173(7). 1907–1926. 22 indexed citations
14.
Record, Éric, et al.. (2013). Production of the Phanerochaete flavido-alba laccase in Aspergillus niger for synthetic dyes decolorization and biotransformation. World Journal of Microbiology and Biotechnology. 30(1). 201–211. 40 indexed citations
15.
Díaz‐Gavilán, Mónica, José A. Gómez-Vidal, Fernando Rodríguez‐Serrano, et al.. (2008). Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies. Bioorganic & Medicinal Chemistry Letters. 18(4). 1457–1460. 31 indexed citations
16.
Marchal, Juan Antonio, Houría Boulaiz, Fernando Rodríguez‐Serrano, et al.. (2007). 5-Fluorouracil Derivatives Induce Differentiation Mediated by Tubulin and HLA Class I Modulation. Medicinal Chemistry. 3(3). 233–239. 12 indexed citations
17.
Marchal, Juan Antonio, María Núñez, Mónica Díaz‐Gavilán, et al.. (2006). A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells. Breast Cancer Research and Treatment. 105(3). 237–246. 26 indexed citations
18.
Gómez-Vidal, José A., Joaquín M. Campos Rosa, Juan Antonio Marchal, et al.. (2004). Actual Targets in Cytodifferentiation Cancer Therapy. Current Topics in Medicinal Chemistry. 4(2). 175–202. 10 indexed citations
19.
Flinspach, M.L., Huiying Li, J. Jamal, et al.. (2003). Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase. Nature Structural & Molecular Biology. 11(1). 54–59. 64 indexed citations
20.
Ronsisvalle, Giuseppe, Orazio Prezzavento, Lorella Pasquinucci, et al.. (1995). CCB, a novel specific κ opioid agonist, which discriminates between opioid and σ1 recognition sites. Life Sciences. 57(16). 1487–1495. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026